[Pharmacokinetic and pharmacodynamic features of palonosetron].
Genazzani
Armando A
AA
Facoltà di Farmacia, Università degli Studi del Piemonte Orientale, Novara.
Billington
Richard A
RA
D000932:Antiemetics / Q000737:chemistry / Q000493:pharmacokinetics* / Q000494:pharmacology*; D017829:Granisetron / Q000494:pharmacology; D006801:Humans; D007211:Indoles / Q000494:pharmacology; D007546:Isoquinolines / Q000737:chemistry / Q000493:pharmacokinetics* / Q000494:pharmacology*; D017294:Ondansetron / Q000494:pharmacology; D000077924:Palonosetron; D011807:Quinolizines / Q000494:pharmacology; D011812:Quinuclidines / Q000737:chemistry / Q000493:pharmacokinetics* / Q000494:pharmacology*; D012702:Serotonin Antagonists / Q000737:chemistry / Q000493:pharmacokinetics* / Q000494:pharmacology*; D000077526:Tropisetron
D000932:Antiemetics; D017829:Granisetron; D007211:Indoles; D007546:Isoquinolines; D017294:Ondansetron; D000077924:Palonosetron; D011807:Quinolizines; D011812:Quinuclidines; D012702:Serotonin Antagonists; D000077526:Tropisetron; C060344:dolasetron